Report From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop

Levine, S. R., Myers, M. G., Barunas, R., Chang, D. S., Dutta, S., Maddess, T., Liebmann, J. M., Sherman, S., Eydelman, M., Sun, J. K., Chambers, W., Wickström, K., Luhmann, U. F. O., Pallinat, M., Glassman, A., Aiello, L. P., Markel, D. S., & Gardner, T. W. (2023). Report From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop. Translational Vision Science & Technology, 12(11), 33. https://doi.org/10.1167/tvst.12.11.33
Authors:
S. Robert Levine
Martin G. Myers
Ryan Barunas
Dolly S. Chang
Sanjoy Dutta
Ted Maddess
Jeffrey M. Liebmann
Steve Sherman
Malvina Eydelman
Jennifer K. Sun
Wiley Chambers
Kerstin Wickström
Ulrich F. O. Luhmann
Martin Pallinat
Adam R. Glassman
Lloyd Paul Aiello
Dorene S. Markel
Thomas W. Gardner
Affiliated Authors:
Jeffrey M. Liebmann
Author Keywords:
clinical endpoints
diabetic retinal disease
diabetic retinopathy
neurovascular unit
Publication Type:
Article
Unique ID:
10.1167/tvst.12.11.33
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created: